Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Immunogenicity and safety of intradermal influenza vaccine in immunocompromized patients: a meta-analysis of randomized controlled trials

Fig. 3

Forest plots of the risk ratio of vaccine safety for intradermal compared with intramuscular administration of influenza vaccine. Systemic side effects: at least one systemic sign or symptom (fever, myalgia, headache, malaise and shivering). Local side effects: at least one injection site reaction (pain, erythema, swelling, pruritus, induration and ecchymosis)

Back to article page